Calithera Biosciences Balance Sheet - Quarterly (NASDAQ:CALA)

Add to My Stocks
$4.8 $0.1 (2.13%) CALA stock closing price Sep 20, 2018 (Closing)

The financial analysis of a company like Calithera Biosciences involves checking the three financial statements of the company in detail, of which the balance sheet is one. Financial strength can be guaged by performing Calithera Biosciences stock analysis and by analyzing the balance sheet. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The Calithera Biosciences balance sheet for 2018 Q2 shows total assets of $158.98M. The company has a asset turnover ratio of 0.41. Also see: Calithera Biosciences revenue and Calithera Biosciences operating cash flow for the same quarter.

View and download Calithera Biosciences quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities85.54M96.12M115.31M126.2M108.23M66.25M41.18M44.67M53.05M54.02M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets1.51M3.02M2.73M4.26M1.85M1.8M1.78M1.61M1.91M2.34M
Total Current Assets
Property Plant & Equipment--3.99M---2.78M---
Accumulated Depreciation--2.24M---1.88M---
Net Property Plant & Equipment
Investment & Advances10.83M20.27M22.36M30.92M41.95M51.74M---2.1M
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets1.08M--1.19M------
Total Assets
Notes Payable----------
Accounts Payable1.12M2.16M1.07M1.26M---1.26M1.44M1.05M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses9.53M10.35M8.93M7.14M5M4.22M4.05M3.48M3.24M2.98M
Income Taxes Payable----------
Other Current Liabilities-17.06M29.01M29.01M29.01M29.01M----
Total Current Liabilities
Deferred Taxes/Income1.16M1.12M3.12M10.02M17.18M24.33M----
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus305.24M302.93M300.9M297.56M295.88M293.85M172.41M167.04M162.63M161.34M
Retained Earnings-157.82M-154.74M-150.33M-139.35M-133.28M-128.09M-122.5M-112.98M-104.43M-94.08M
Treasury Stock----------
Other Liabilities-0.25M-0.32M-0.27M-0.12M-0.13M-0.03M-0.01M-0.25M--
Shareholders Equity147.17M147.86M150.3M158.09M162.46M165.73M49.9M53.81M58.21M67.26M
Total Liabilities & Shareholders Equity158.98M178.58M192.45M205.54M214.08M223.9M54.79M58.92M63.22M71.56M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Calithera Biosciences historical stock prices and the current Calithera Biosciences stock price can tell you how the stock price has moved, whereas the Calithera Biosciences PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the Calithera Biosciences company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Calithera Biosciences had total assets of $158.98M.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Calithera Biosciences's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for CALA stock stand at $11.81M.

Calithera Biosciences Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio